Sex-based differences in glycaemic variability and clinical outcomes among older inpatients with type 2 diabetes: insights from the GLIMPACT study
Aging Clinical and Experimental Research · 18.08.2026
DOI: 10.1007/s40520-026-03475-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Clinical and Experimental Research, online erschienen am 18.08.2026. Verfasst von Nicola Confortin und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Padova.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Glycaemic variability (GV) has emerged as a potential marker of adverse outcomes in hospitalised patients with diabetes, yet its clinical impact in older adults and the role of sex differences remain unclear.
Aims
To evaluate the association between in-hospital GV and length of stay (LOS) and one- and two-year all-cause mortality in older adults with type 2 diabetes, and to explore sex-specific patterns.
Methods
Retrospective observational study of patients aged ≥ 65 years with type 2 diabetes admitted to a geriatric unit (2018–2020). GV was assessed using the coefficient of variation (CV) of point-of-care glucose measurements (POCT). Multivariable linear regression and Cox proportional hazards models were applied, adjusting for relevant confounders, with analyses stratified by sex.
Results
A total of 283 patients (59.7% female, mean age 84.9 ± 6.9 years) were included. Higher GV was independently associated with longer LOS in the overall cohort (β = 0.194, 95% CI 0.078–0.310, p = 0.001) and in females, but not in males. Higher GV was associated with increased one-year mortality in females (HR = 1.02, 95% CI 1.00–1.04, p = 0.019), while an inverse association was observed in males. At two years, GV remained associated with mortality only in females.
Discussion
Sex differences in insulin sensitivity and counter-regulatory responses may partly explain these findings. The inverse association in males should be interpreted cautiously, possibly reflecting residual confounding from a higher prevalence of SARS-CoV-2 infection.
Conclusion
In-hospital GV was associated with longer hospital stay and higher mortality in older adults with type 2 diabetes, particularly among females, suggesting it may represent a potential marker of clinical vulnerability warranting sex-specific approaches to glycaemic management.
Förderung
- Università degli Studi di Padova
Zitieren
APA
Confortin, N., Ceolin, C., Vergadoro, M., Marzio, B. D., Ferra, E., Ambrosio, A., Catalani, F., Gasparini, G., Zanforlini, B. M., Curreri, C., Spiezia, L., Rossi, A., Sergi, G., & Rui, M. D. (2026). Sex-based differences in glycaemic variability and clinical outcomes among older inpatients with type 2 diabetes: insights from the GLIMPACT study. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-026-03475-4
Vancouver
Confortin N, Ceolin C, Vergadoro M, Marzio BD, Ferra E, Ambrosio A, et al. Sex-based differences in glycaemic variability and clinical outcomes among older inpatients with type 2 diabetes: insights from the GLIMPACT study. Aging Clinical and Experimental Research. 2026. doi:10.1007/s40520-026-03475-4
BibTeX
@article{Confortin2026,
author = {Confortin, Nicola and Ceolin, Chiara and Vergadoro, Margherita and Marzio, Benedetta Di and Ferra, Elisabetta and Ambrosio, Andrea and Catalani, Filippo and Gasparini, Giulia and Zanforlini, Bruno Micael and Curreri, Chiara and Spiezia, Luca and Rossi, Andrea and Sergi, Giuseppe and Rui, Marina De},
title = {Sex-based differences in glycaemic variability and clinical outcomes among older inpatients with type 2 diabetes: insights from the GLIMPACT study},
journal = {Aging Clinical and Experimental Research},
year = {2026},
doi = {10.1007/s40520-026-03475-4}
}
EUVIMED